104 related articles for article (PubMed ID: 25043081)
21. Correlation between MMP1-PAR1 axis and clinical outcome of primary gallbladder carcinoma.
Du X; Wang S; Lu J; Cao Y; Song N; Yang T; Dong R; Zang L; Yang Y; Wu T; Li J
Jpn J Clin Oncol; 2011 Sep; 41(9):1086-93. PubMed ID: 21835828
[TBL] [Abstract][Full Text] [Related]
22. Role of CD151 expression in gallbladder carcinoma.
Matsumoto N; Morine Y; Utsunomiya T; Imura S; Ikemoto T; Arakawa Y; Iwahashi S; Saito Y; Yamada S; Ishikawa D; Takasu C; Miyake H; Shimada M
Surgery; 2014 Nov; 156(5):1212-7. PubMed ID: 24890568
[TBL] [Abstract][Full Text] [Related]
23. SHP2 and UGP2 are Biomarkers for Progression and Poor Prognosis of Gallbladder Cancer.
Wang Q; Yang ZL; Zou Q; Yuan Y; Li J; Liang L; Zeng G; Chen S
Cancer Invest; 2016 Jul; 34(6):255-64. PubMed ID: 27389087
[TBL] [Abstract][Full Text] [Related]
24. Expression of CDC6 and GDF-9 and their clinicopathological significances in benign and malignant lesions of the gallbladder.
Shu GS; Yang LP; Yang ZL; Jiang S
Cancer Biomark; 2012; 11(2-3):107-14. PubMed ID: 23011157
[TBL] [Abstract][Full Text] [Related]
25. [Expression and clinical significance of highly expressed protein in cancer (Hec 1) in human primary gallbladder carcinoma].
Xiao GF; Tang HH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Sep; 24(9):910-2. PubMed ID: 18782526
[TBL] [Abstract][Full Text] [Related]
26. MCL1 participates in leptin-promoted mitochondrial fusion and contributes to drug resistance in gallbladder cancer.
Wang WJ; Lai HY; Zhang F; Shen WJ; Chu PY; Liang HY; Liu YB; Wang JM
JCI Insight; 2021 Aug; 6(15):. PubMed ID: 34156978
[TBL] [Abstract][Full Text] [Related]
27. Increased expression of RBMS3 predicts a favorable prognosis in human gallbladder carcinoma.
Wu Y; Meng D; You Y; Sun R; Yan Q; Bao J; Sun Y; Yun D; Li Y; Sun D
Oncol Rep; 2020 Jul; 44(1):55-68. PubMed ID: 32627033
[TBL] [Abstract][Full Text] [Related]
28. Low p27Kip1 expression is an independent prognostic factor in gallbladder carcinoma.
Filipits M; Puhalla H; Wrba F
Anticancer Res; 2003; 23(1B):675-9. PubMed ID: 12680166
[TBL] [Abstract][Full Text] [Related]
29. The ERK/MAPK pathway is overexpressed and activated in gallbladder cancer.
Buchegger K; Silva R; López J; Ili C; Araya JC; Leal P; Brebi P; Riquelme I; Roa JC
Pathol Res Pract; 2017 May; 213(5):476-482. PubMed ID: 28285962
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of HIF-1α in primary gallbladder carcinoma and its relation to vasculogenic mimicry and unfavourable prognosis.
Sun W; Shen ZY; Zhang H; Fan YZ; Zhang WZ; Zhang JT; Lu XS; Ye C
Oncol Rep; 2012 Jun; 27(6):1990-2002. PubMed ID: 22470047
[TBL] [Abstract][Full Text] [Related]
31. Correlated high expression of FXR and Sp1 in cancer cells confers a poor prognosis for pancreatic cancer: A study based on TCGA and tissue microarray.
Hu H; Wu LL; Han T; Zhuo M; Lei W; Cui JJ; Jiao F; Wang LW
Oncotarget; 2017 May; 8(20):33265-33275. PubMed ID: 28402278
[TBL] [Abstract][Full Text] [Related]
32. Connective tissue growth factor immunohistochemical expression is associated with gallbladder cancer progression.
Garcia P; Leal P; Alvarez H; Brebi P; Ili C; Tapia O; Roa JC
Arch Pathol Lab Med; 2013 Feb; 137(2):245-50. PubMed ID: 23368866
[TBL] [Abstract][Full Text] [Related]
33. New prognostic factor influencing long-term survival of patients with advanced gallbladder carcinoma.
Miura F; Asano T; Amano H; Toyota N; Wada K; Kato K; Takada T; Takami H; Ohira G; Matsubara H
Surgery; 2010 Aug; 148(2):271-7. PubMed ID: 20570306
[TBL] [Abstract][Full Text] [Related]
34. Fascin overexpression correlates with positive thrombospondin-1 and syndecan-1 expressions and a more aggressive clinical course in patients with gallbladder cancer.
Roh YH; Kim YH; Choi HJ; Lee KE; Roh MS
J Hepatobiliary Pancreat Surg; 2009; 16(3):315-21. PubMed ID: 19259612
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical expression and prognostic value of CD97 and its ligand CD55 in primary gallbladder carcinoma.
Wu J; Lei L; Wang S; Gu D; Zhang J
J Biomed Biotechnol; 2012; 2012():587672. PubMed ID: 22547928
[TBL] [Abstract][Full Text] [Related]
36. Upregulation of eukaryotic translation initiation factor 4E associates with a poor prognosis in gallbladder cancer and promotes cell proliferation in vitro and in vivo.
Fang D; Peng J; Wang G; Zhou D; Geng X
Int J Mol Med; 2019 Oct; 44(4):1325-1332. PubMed ID: 31432159
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of nemo-like kinase (NLK) expression in patients with gallbladder cancer.
Li M; Zhang S; Wang Z; Zhang B; Wu X; Weng H; Ding Q; Tan Z; Zhang N; Mu J; Yang J; Shu Y; Bao R; Ding Q; Wu W; Cao Y; Liu Y
Tumour Biol; 2013 Dec; 34(6):3995-4000. PubMed ID: 23857283
[TBL] [Abstract][Full Text] [Related]
38. Clinical implication of TMPRSS4 expression in human gallbladder cancer.
Wu XY; Zhang L; Zhang KM; Zhang MH; Ruan TY; Liu CY; Xu JY
Tumour Biol; 2014 Jun; 35(6):5481-6. PubMed ID: 24532432
[TBL] [Abstract][Full Text] [Related]
39. [The role of tissue factor pathway inhibitor-2 gene in gallbladder cancer].
Qin YY; Gong W; Weng MZ; Li JY; Quan ZW
Zhonghua Wai Ke Za Zhi; 2012 Dec; 50(12):1099-103. PubMed ID: 23336488
[TBL] [Abstract][Full Text] [Related]
40. Down-Regulated Phosphoglycerate Kinase 1 Expression Is Associated With Poor Prognosis in Patients With Gallbladder Cancer.
Lu W; Gao J; Yang J; Cao Y; Jiang L; Li M; Zhang Y; Zhou J; Liu Y
Medicine (Baltimore); 2015 Dec; 94(49):e2244. PubMed ID: 26656369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
